Neuromuscular disease in the dialysis patient: an update for the nephrologist.
Neuromuscular disease is an extremely common complication of end-stage kidney disease (ESKD), manifesting in almost all dialysis patients, and leading to weakness, reduced exercise capacity, and disability. Recent studies have suggested that hyperkalemia may underlie the development of neuropathy. As such, maintenance of serum K(+) within normal limits between periods of dialysis in ESKD patients manifesting early neuropathic symptoms may reduce neuropathy development and progression. For patients with more severe neuropathic syndromes, increased dialysis frequency or a switch to high-flux dialysis may prevent further deterioration, while ultimately, renal transplantation is required to improve and restore nerve function. Exercise training programs are beneficial for ESKD patients with muscle weakness due to neuropathy or myopathy, and are capable of improving exercise tolerance and quality of life. Specific treatments have recently been evaluated for symptoms of autonomic neuropathy, including sildenafil for impotence and midodrine for intra-dialytic hypotension, and have been shown to be effective and well tolerated. Other important management strategies for neuropathy include attention to foot care to prevent callus and ulceration, vitamin supplementation, and erythropoietin. Treatment with membrane-stabilizing agents, such as amitryptiline and gabapentin, are highly effective in patients with painful neuropathy.
Krishnan
Arun V
AV
Prince of Wales Medical Research Institute, Barker Street, Randwick, Sydney, NSW 2031, Australia.
Pussell
Bruce A
BA
Kiernan
Matthew C
MC
D005081:Exercise Therapy / Q000379:methods*; D014943:Global Health; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D009017:Morbidity / Q000639:trends; D009468:Neuromuscular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011379:Prognosis; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors